ALL vs RLMD · P/E 4.9, $56.89B cap vs $692.3M cap
The Allstate Corporation (ALL) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
The Allstate Corporation (ALL) is a insurance - property & casualty company listed on US.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
ALL does not have a complete income-statement cache yet.
RLMD does not have a complete income-statement cache yet.
ALL currently screens at market cap $56.89B and trailing P/E 4.9. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the ALL and RLMD stock pages for the full models.
Not investment advice.